Review Shows High Prevalence of Fatigue in Adults With IBD

MONDAY, April 18, 2022 (HealthDay News) -- Adults with inflammatory bowel disease (IBD) have a high prevalence of fatigue, according to a review published in the May issue of Clinical Gastroenterology and Hepatology.
Adrijana D'Silva, from the University of Calgary in Canada, and colleagues conducted a systematic review and meta-analysis to examine the global prevalence, risk factors, and impact of fatigue in adults with IBD. Data from 20 studies were included in the review and meta-analysis; the studies were of good quality overall.
The researchers found that the pooled prevalence of fatigue was 47 percent, although there was high heterogeneity between studies (I2 = 98 percent). The prevalence of fatigue varied significantly based on the definition of fatigue (chronic and high, 28 and 48 percent, respectively) and disease status (active disease and remission, 72 and 47 percent, respectively). The most commonly reported fatigue-related risk factors were sleep disturbance, anxiety, depression, and anemia.
"Future studies should focus on better understanding the risk factors of fatigue and how addressing these may modify fatigue burden and its impact," the authors write. "Addressing fatigue in a clinical setting and the development of targeted interventions aimed at managing fatigue should be of high priority among patients with IBD."
One author disclosed financial ties to Allergan.
Related Posts
Pfizer afirma que el refuerzo de la vacuna debería proteger contra la variante ómicron
MIÉRCOLES, 8 de diciembre de 2021 (HealthDay News) -- Pfizer/BioNTech señaló el...
Newborns Should Receive Vitamin K Within Six Hours of Birth
TUESDAY, Feb. 22, 2022 (HealthDay News) -- Vitamin K should be administered as a...
How Healthy Is Horror?
FRIDAY, Oct. 28, 2022 (HealthDay News) -- That intense feeling of fear as you...
Las máscaras N-95 son indispensables para la ómicron, pero hay muchas falsificaciones
JUEVES, 30 de diciembre de 2021 (HealthDay News) -- Mientras ve cómo la variante...
